ChemoCentryx Inc. ’s (CCXI) share price has entered into oversold territory with an RSI value of 21.70. The Zacks Consensus Estimate on ChemoCentryx Inc.’s loss for the full year period has decreased by 11 cents over the past two months to $1.03 per share. Currently, ChemoCentryx Inc is a Zacks #2 Rank (“Buy”), suggesting that now might be a good time to get in on (CCXI) after its recent drop.
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment